<?xml version="1.0" encoding="UTF-8"?>
<p id="Par92">If the interim analysis shows a significant difference, the investigators and DSMB will be un-blinded to the study groups and make any stopping decision on the basis of the nature of any AEs and/or SAEs and ethical grounds, as well as consideration of any statistical differences between the groups. Grounds for stopping on evidence of clear benefit will be considered. The Peto approach will be taken with symmetric stopping boundaries at 
 <italic>p</italic> = 0.001.
</p>
